Old Web
English
Sign In
Acemap
>
Paper
>
1284P MET inhibitor capmatinib plus EGFR tyrosine kinase inhibitor nazartinib for EGFR-mutant non-small cell lung cancer
1284P MET inhibitor capmatinib plus EGFR tyrosine kinase inhibitor nazartinib for EGFR-mutant non-small cell lung cancer
2020
Eudald Felip
V Minotti
Ross A. Soo
Juergen Wolf
Ben Solomon
D.S.W. Tan
A. Ardizzoni
Do-Wan Lee
Lecia V. Sequist
Fabrice Barlesi
Luis Paz-Ares
Delvys Rodriguez Abreu
M. R. Garcia-Campelo
M. Sprauten
L O'Sullivan-Djentuh
Riccardo Belli
S Glaser
M. Zou
M. Giovannini
J.C-H. Yang
Keywords:
Cancer research
non small cell
egfr tyrosine kinase
Lung cancer
Medicine
Mutant
Capmatinib
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
3
Citations
NaN
KQI
[]